Liver cancer, also known as hepatocellular carcinoma, is a serious condition that can be life-threatening if not detected and treated promptly. The deadliness of liver cancer is influenced by several factors, including the stage at which it is diagnosed, the presence of underlying liver disease, the patient's overall health, and the effectiveness of the treatment options available. For the 43% of people who are diagnosed at an early stage, the 5-year survival rate is 31%. This statistic indicates that a significant portion of patients diagnosed early can expect to live for at least five years after their diagnosis. However, if liver cancer has spread to surrounding tissues or organs and/or the regional lymph nodes, the 5-year survival rate drops significantly to 11%. This suggests that the cancer's aggressiveness and the extent of its spread play a crucial role in the prognosis. When the cancer has metastasized to a distant part of the body, the 5-year survival rate further decreases to a concerning 3%. At this stage, the cancer is considered advanced, and treatment options may be more focused on palliative care to improve the quality of life rather than curative measures. It is important to note that survival rates are based on statistical data and do not predict individual outcomes. Each patient's situation is unique, and medical advancements continue to improve treatment options and survival rates for those with liver cancer. read more >>

For the 43% of people who are diagnosed at an early stage, the 5-year survival rate is 31%. If liver cancer has spread to surrounding tissues or organs and/or the regional lymph nodes, the 5-year survival rate is 11%. If the cancer has spread to a distant part of the body, the 5-year survival rate is 3%.read more >>